Clinical Trials Logo

Diabetic Foot Ulcer (DFU) clinical trials

View clinical trials related to Diabetic Foot Ulcer (DFU).

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04372355 Completed - Clinical trials for Diabetic Foot Ulcer (DFU)

Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

Start date: June 19, 2019
Phase: Phase 2
Study type: Interventional

Study in adult Diabetes Mellitus patients with diabetic foot ulcers and elevated HbA1c who will receive standard wound treatment in combination with adjuvant therapy WF10 to compare the change of HbA1c levels at baseline and after treatment.

NCT ID: NCT04277598 Completed - Clinical trials for Diabetic Foot Ulcer (DFU)

A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer

Start date: October 9, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

The MARSYAS II study which will be conducted in patients with diabetic foot ulcer (DFU) consists of a Lead-In Phase for safety assessment of multiple doses of the biologic investigational medicinal product (IMP) APO-2 and of a Main Phase (Phase II Study) to assess the efficacy and safety of the IMP. The phase II study will be a randomized study at multiple clinical centers and it will be double-blind meaning that neither the investigator nor the treated patient know if the IMP or a placebo is applied; the study will investigate the safety and clinical efficacy of multiple dose administrations at three dose levels of APO-2 (low dose, medium dose or high dose) compared with placebo.

NCT ID: NCT01912092 Completed - Clinical trials for Diabetic Foot Ulcer (DFU)

Askina Calgitrol Paste Diabetic Foot Ulcers

Start date: April 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of Askina® Calgitrol® Paste in reducing local infection in subjects treated for mildly infected Diabetic Foot Ulcers (DFU) with Askina® Calgitrol® Paste.